Transgene Biotek Ltd.
| BSE: 526139 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE773D01018 |
| BSE 00:00 | 08 Aug | 3.30 |
0.07 (2.17%) |
OPEN
3.38 |
HIGH
3.38 |
LOW
3.17 |
| NSE 05:30 | 01 Jan | Transgene Biotek Ltd |
| OPEN | 3.38 |
| PREVIOUS CLOSE | 3.23 |
| VOLUME | 17458 |
| 52-Week high | 4.88 |
| 52-Week low | 3.02 |
| P/E | |
| Mkt Cap.(Rs cr) | 25 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 910.50 | -0.51 | 966.90 | 733.95 | 218456.26 |
| Divi's Lab. | 3938.65 | 0.71 | 5425.00 | 3365.10 | 104551.46 |
| Cipla | 1029.25 | -0.48 | 1083.15 | 850.00 | 83060.47 |
| Dr Reddy's Labs | 4220.35 | 1.55 | 5078.80 | 3655.00 | 70243.51 |
| Apollo Hospitals | 4428.60 | 1.27 | 5930.70 | 3365.90 | 63674.41 |
| Torrent Pharma. | 1557.25 | 0.10 | 1652.23 | 1242.50 | 52703.57 |
| Abbott India | 20292.20 | -0.51 | 23902.30 | 15525.00 | 43120.92 |
| Piramal Enterp. | 1790.70 | 3.67 | 3013.00 | 1561.00 | 42735.06 |
| Gland Pharma | 2325.55 | 2.86 | 4350.00 | 2180.10 | 38301.81 |
| Biocon | 313.60 | 0.19 | 410.50 | 305.00 | 37650.82 |
| Max Healthcare | 381.55 | 1.67 | 472.60 | 279.00 | 36996.23 |
| Zydus Lifesci. | 360.60 | 0.95 | 590.00 | 319.40 | 36914.62 |
| Alkem Lab | 2985.40 | -4.06 | 4067.70 | 2835.00 | 35690.46 |
| Aurobindo Pharma | 568.20 | -0.06 | 902.45 | 503.40 | 33290.84 |
| Lupin | 666.05 | -0.28 | 1156.95 | 583.05 | 30281.96 |
| Laurus Labs | 550.80 | 1.02 | 723.55 | 433.20 | 29597.24 |
| Ipca Labs. | 1012.10 | -0.30 | 1383.55 | 831.40 | 25676.98 |
| Glaxosmi. Pharma | 1442.75 | 2.48 | 1917.00 | 1372.80 | 24441.63 |
| Syngene Intl. | 576.00 | 2.03 | 686.00 | 508.10 | 23122.37 |
| Fortis Health. | 269.50 | 1.79 | 313.80 | 219.80 | 20346.17 |
Quick Links for Transgene Biotek:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
